NURO Logo

NeuroMetrix, Inc. (NURO) 

NASDAQ
Market Cap
$7.84M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
642 of 776
Rank in Industry
82 of 100

Largest Insider Buys in Sector

NURO Stock Price History Chart

NURO Stock Performance

About NeuroMetrix, Inc.

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance …

Insider Activity of NeuroMetrix, Inc.

Over the last 12 months, insiders at NeuroMetrix, Inc. have bought $0 and sold $4,580 worth of NeuroMetrix, Inc. stock.

On average, over the past 5 years, insiders at NeuroMetrix, Inc. have bought $106,754 and sold $401,640 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 28,238 shares for transaction amount of $96,574 was made by Topline Capital Partners, LP (10 percent owner) on 2021‑06‑10.

List of Insider Buy and Sell Transactions, NeuroMetrix, Inc.

2024-04-22Saledirector
1,000
0.0504%
$4.58$4,580-15.32%
2021-08-25SaleSenior Vice President, CFO
50,000
0.8709%
$10.55$527,500-58.07%
2021-08-12SaleSenior Vice President, CFO
20,000
0.338%
$13.56$271,200-67.40%
2021-06-10Purchase10 percent owner
28,238
0.6957%
$3.42$96,574+49.10%
2021-06-10Purchase
28,238
0.6957%
$3.42$96,574+49.10%
2020-06-11PurchasePresident & CEO
1,000
0.0334%
$1.84$1,840+36.89%
2020-05-21PurchasePresident & CEO
500
0.0168%
$2.33$1,165-7.83%
2020-05-14PurchasePresident & CEO
1,000
0.0333%
$2.18$2,180-2.53%
2020-05-13PurchasePresident & CEO
250
0.0089%
$2.46$615-7.24%
2020-05-12PurchasePresident & CEO
500
0.0161%
$2.28$1,140-10.00%
2020-05-08PurchasePresident & CEO
1,000
0.0337%
$2.07$2,070+3.43%
2020-05-07PurchasePresident & CEO
1,000
0.0338%
$2.11$2,110+1.69%
2020-05-06PurchasePresident & CEO
1,000
0.0318%
$2.03$2,030-0.94%
2020-05-05PurchasePresident & CEO
1,000
0.0338%
$2.29$2,290-6.67%
2020-04-30PurchasePresident & CEO
2,000
0.0663%
$2.46$4,920-14.63%
2018-10-29SalePresident & CEO
3,760
0.0514%
$1.18$4,437-40.17%
2018-03-02PurchasePresident & CEO
1,000
0.0131%
$1.29$1,294-7.97%
2018-03-01PurchaseSenior Vice President, CFO
1,000
0.0138%
$1.33$1,333-5.93%
2018-02-23PurchasePresident & CEO
1,500
0.0237%
$1.54$2,310-6.57%
2018-02-21PurchasePresident & CEO
1,000
0.0147%
$1.45$1,453-6.52%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.